-
Something wrong with this record ?
Organic Salts of Pharmaceutical Impurity p-Aminophenol
UBR. Khandavilli, L. Keshavarz, E. Skořepová, RRE. Steendam, PJ. Frawley
Language English Country Switzerland
Document type Journal Article
Grant support
12/RC/2275
Science Foundation Ireland - Ireland
17-23196S
Grantová Agentura České Republiky
NLK
Directory of Open Access Journals
from 1997
Free Medical Journals
from 1997
PubMed Central
from 2001
Europe PubMed Central
from 2001
ProQuest Central
from 1997-01-01
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 2009-03-01
Health & Medicine (ProQuest)
from 1997-01-01
- MeSH
- Aminophenols chemistry MeSH
- Drug Contamination * MeSH
- Crystallography, X-Ray MeSH
- Pharmaceutical Preparations analysis chemistry standards MeSH
- Models, Molecular MeSH
- Molecular Structure MeSH
- Organic Chemicals chemistry MeSH
- Powders MeSH
- Salts chemistry MeSH
- Publication type
- Journal Article MeSH
The presence of impurities can drastically affect the efficacy and safety of pharmaceutical entities. p-Aminophenol (PAP) is one of the main impurities of paracetamol (PA) that can potentially show toxic effects such as maternal toxicity and nephrotoxicity. The removal of PAP from PA is challenging and difficult to achieve through regular crystallization approaches. In this regard, we report four new salts of PAP with salicylic acid (SA), oxalic acid (OX), l-tartaric acid (TA), and (1S)-(+)-10-camphorsulfonic acid (CSA). All the PAP salts were analyzed using single-crystal X-ray diffraction, powder X-ray diffraction, infrared spectroscopy, differential scanning calorimetry, and thermogravimetric analysis. The presence of minute amounts of PAP in paracetamol solids gives a dark color to the product that was difficult to remove through crystallization. In our study, we found that the addition of small quantities of the aforementioned acids helps to remove PAP from PA during the filtration and washings. This shows that salt formation could be used to efficiently remove challenging impurities.
Institute of Physics ASCR Na Slovance 2 182 21 Praha 8 Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012691
- 003
- CZ-PrNML
- 005
- 20210507103644.0
- 007
- ta
- 008
- 210420s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules25081910 $2 doi
- 035 __
- $a (PubMed)32326160
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Khandavilli, U B Rao $u Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland $u PSC Biotech Limited, Blanchardstown, Dublin 15, Ireland
- 245 10
- $a Organic Salts of Pharmaceutical Impurity p-Aminophenol / $c UBR. Khandavilli, L. Keshavarz, E. Skořepová, RRE. Steendam, PJ. Frawley
- 520 9_
- $a The presence of impurities can drastically affect the efficacy and safety of pharmaceutical entities. p-Aminophenol (PAP) is one of the main impurities of paracetamol (PA) that can potentially show toxic effects such as maternal toxicity and nephrotoxicity. The removal of PAP from PA is challenging and difficult to achieve through regular crystallization approaches. In this regard, we report four new salts of PAP with salicylic acid (SA), oxalic acid (OX), l-tartaric acid (TA), and (1S)-(+)-10-camphorsulfonic acid (CSA). All the PAP salts were analyzed using single-crystal X-ray diffraction, powder X-ray diffraction, infrared spectroscopy, differential scanning calorimetry, and thermogravimetric analysis. The presence of minute amounts of PAP in paracetamol solids gives a dark color to the product that was difficult to remove through crystallization. In our study, we found that the addition of small quantities of the aforementioned acids helps to remove PAP from PA during the filtration and washings. This shows that salt formation could be used to efficiently remove challenging impurities.
- 650 _2
- $a aminofenoly $x chemie $7 D000627
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 12
- $a kontaminace léku $7 D004340
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a organické látky $x chemie $7 D009930
- 650 _2
- $a léčivé přípravky $x analýza $x chemie $x normy $7 D004364
- 650 _2
- $a prášky, zásypy, pudry $7 D011208
- 650 _2
- $a soli $x chemie $7 D012492
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Keshavarz, Leila $u Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland
- 700 1_
- $a Skořepová, Eliška $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 16628 Prague 6, Czech Republic $u Institute of Physics ASCR, Na Slovance 2, 182 21 Praha 8, Czech Republic
- 700 1_
- $a Steendam, René R E $u Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland
- 700 1_
- $a Frawley, Patrick J $u Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 25, č. 8 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32326160 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507103643 $b ABA008
- 999 __
- $a ok $b bmc $g 1650954 $s 1133070
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 25 $c 8 $e 20200421 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- GRA __
- $a 12/RC/2275 $p Science Foundation Ireland $2 Ireland
- GRA __
- $a 17-23196S $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20210420